Login / Signup

C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids.

Yusuke YoshidaTomohiro SugimotoYohei HosokawaHarumichi SumaHiroki KobayashiMichinori IshitokuHiroki KohnoTadahiro TokunagaHirofumi WatanabeSho MokudaTakaki NojimaShintaro HirataEiji Sugiyama
Published in: Modern rheumatology (2021)
High CRP levels with non-widespread GGO predicted progressive ILD in patients with SSc treated with CYC.
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • rheumatoid arthritis
  • idiopathic pulmonary fibrosis
  • multiple sclerosis
  • low dose
  • high dose
  • combination therapy
  • newly diagnosed